Spinal Stimulation and Mobility Devices

N/ARecruitingNCT05520359

University of Washington20 enrolled

Overview

This research study will combine non-invasive spinal stimulation with mobility devices to examine the acute impact of the individual and combined effects of these innovative techniques on mobility in children with cerebral palsy.

For people with neurological conditions, excessive and inappropriate muscle activity resulting from injured sensory pathways (e.g., spasticity or hypertonicity) contributes to inefficient movement, bone deformities, pain, and other comorbidities. Research with humans and animals have highlighted the critical importance of both motor and sensory pathways for motor learning after neurologic injury. However, the best techniques for engaging motor and sensory pathways in a way that brings high quality mobility are not well understood. With this study we will examinee how increased sensory feedback, through mobility device use and electrical spinal stimulation, impact movement mechanics in people with neurological conditions to inform long-term studies and eventual implementation into clinical practice. Mobility devices offer a promising approach to improve mobility rehabilitation through engagement of sensory and motor pathways. These devices can either assist in movement by providing support to perform an activity or they can be used to provide resistance to build strength. Mechanistically how these devices impact movement mechanics is still not well understood. Electrical spinal stimulation with intensive, repetitive training has demonstrated exciting potential to improve limb function after neurologic injury. Spinal stimulation has shown to improve motor function with long-term training. Stimulation is hypothesized to improve motor pathways through boosting sensory input. However, the neuromechanical effects of stimulation as a result of increased sensory feedback over an acute time frame has not been explored in efforts to test this hypothesis. This study aims to evaluate the acute effects of increased afferent feedback in individuals with neurological conditions via mobility devices and spinal stimulation. Understanding how these approaches affect the quantity and quality of movement in the short term is a first step before determining potential treatment outcomes. In this research, we will quantify the neuromechanics of movement with and without these approaches for individuals with neurologic disorders.

Study Type

INTERVENTIONAL

Allocation

Purpose

BASIC_SCIENCE

Masking

NONE

Enrollment

Conditions

Cerebral Palsy Stroke Premature Birth Hypoxic-Ischemic Encephalopathy Periventricular Leukomalacia

Interventions

Mobility DeviceDEVICE

Use of mobility device during session.

Spinal StimulationDEVICE

A stimulator will be used non-invasively stimulate the spine at the neck and/or lower back (cervical and/or lum

Eligibility

Sex: ALLMin age: 4 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * have a neurologic condition * are 4-70 years of age * have stable medical condition * can perform simple cued motor tasks and who can follow 2-3 step commands * who are volunteering to be involved in this study * can provide feedback on comfort and experience during lab visits Exclusion Criteria: * have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation. * have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention * have a history of uncontrolled seizures * have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities * are dependent on ventilation support * have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump) * have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months * have established osteoporosis and taking medication for osteoporosis treatment. * have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.) * have active cancer

Locations (1)

University of Washington

Seattle, Washington, United States

RECRUITING

Outcomes

Primary Outcomes

Muscle Coordination

Change in level of co-contraction between the plantarflexor and tibialis anterior muscles during the gait cycle monitored from electromyography recordings.

Time frame: Comparing first and last minute of walking on treadmill at each experimental session.

Secondary Outcomes

Modified Ashworth Scale

Change in summed score of spasticity from lower-extremity muscles. Lower values indicate less spasticity.

Time frame: Physical exam conducted at the beginning and end of each experimental session.

Plantarflexor Muscle Strength

Change in maximum voluntary contraction level of the plantarflexor muscles taken as the average of three trials where the participant exerts the maximum amount of force measured from a handheld dynamometer with verbal encouragement.

Time frame: Physical exam conducted at the beginning and end of experimental session.

Central Contacts

Katherine Steele, PHD

CONTACT

206-685-2390 kmsteele@uw.edu

Katie Landwehr, MS

CONTACT

937-231-1205 klandweh@uw.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.